Rivastigmine in Chinese patients with subcortical vascular dementia

BACKGROUND: We explored the efficacy and tolerability of rivastigmine among Chinese patients with subcortical vascular dementia. METHODS: Forty subjects were randomized to either placebo (n = 20) or rivastigmine (n = 20) in a double-blind 26-week trial. Outcome measures were cognition (mini-mental s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mok, Vincent, Wong, Adrian, Ho, Simon, Leung, Thomas, Lam, Wynnie WM, Wong, Ka Sing
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656338/
https://www.ncbi.nlm.nih.gov/pubmed/19300631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656338/
https://www.ncbi.nlm.nih.gov/pubmed/19300631

Ejemplares similares